Investigators reported on all 17 patients with BPDCN who underwent allogeneic hematopoietic cell transplantation (allo-HCT) at their center between 2000 and 2020, and concluded that allo-HCT provided long-lasting remissions in BPDCN patients, particularly when performed in complete remission.
[Bone Marrow Transplantation]
7992332
{7992332:AAAAAAAA}
apa
50
1
167731
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
